online glp-1 Telehealth's 'gold rush' is powered by these medical groups GLP-1 online advertising overstates benefits

revenue in Q4 2024, a sharp rise from USD 175.8 million in Q4 2023

In prolonged cases, topical corticosteroids may help relieve symptoms and decrease duration of hospitalization

This assessment identifies which areas are accelerating fastest and likely to reshape the competitive landscape over the coming years

The data was processed and scaled with DIALS 67 and Aimless 68 within the CCP4 suite 69

Patients with mild gynecomastia symptoms and good skin quality may benefit from non-surgical gynecomastia treatment with Kybella injections

Food and Drug Administration cleared Ascletis Pharma to start a Phase 1 clinical trial of ASC35 , a once-monthly subcutaneous peptide that activates both the GLP-1 and GIP receptors